Patients with melanoma who were treated with a combination of Opdivo and Yervoy showed no significant changes in their quality of life when compared to those who were treated with either agent alone.
Barbara Boughton
Advertisement
Articles by Barbara Boughton
Advertisement
Latest Updated Articles
- QOL Similar With Checkpoint Combo Versus Single-Agent Immunotherapy in Melanoma
Published: May 31st 2016 | Updated:
Advertisement
Advertisement
Trending on CURE
1
SUNRiSE-1 Participant Shares Insights on Bladder Cancer Education
2
Fertility Preservation During Breast Cancer: ‘I Would Do It All Again’
3
What Are My Options for Liver Cancer Treatment?
4
Becoming Cancer-Aware: How My Diagnosis Changed the Way My Family Sees Everyday Products
5
